ODTX ODYSSEY THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, ODYSSEY THERAPEUTICS INC reported revenue of $0 (down 100.0% from a year earlier), net income of −$52.8M and diluted EPS of −$1.74.
ODTX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0 (down 100.0% year over year), net income −$52.8M, EPS −$1.74
- Quarter ended Mar 31, 2026: revenue $0 (down 100.0% year over year), net income −$38.3M, EPS −$6.77
- Quarter ended Jun 30, 2025: revenue $959K, net income −$41.2M, EPS −$29.54
- Quarter ended Mar 31, 2025: revenue $1.92M, net income −$38.4M, EPS −$39.37
ODTX balance sheet
- Jun 30, 2026: cash $82.0M, total assets $484M, total liabilities $62.6M, shareholders' equity $421M
- Mar 31, 2026: cash $35.7M, total assets $229M, total liabilities $49.2M, shareholders' equity −$524M
- Dec 31, 2025: cash $41.7M, total assets $270M, total liabilities $54.5M, shareholders' equity −$488M